FOXO Technologies Inc. (FOXO)

Market Cap	330.27K -93.4%
Revenue (ttm)	14.76M +1,000.0%
Net Income	-23.24M
EPS	-1.65
Shares Out	3.30B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,773,243
Average Volume	23,395,481
Open	0.0001
Previous Close	0.0001
Day's Range	0.0000 - 0.0001
52-Week Range	0.0000 - 4.7360
Beta	2.59
RSI	49.73
Earnings Date	Mar 27, 2026

About FOXO Technologies

FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. The company operates through two segments: Healthcare and Labs and Life. The company offers behavioural health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; and other services. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomark...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2020
• Employees: 168
• Stock Exchange: OTCMKTS
• Ticker Symbol: FOXO

Financial Performance

In 2024, FOXO Technologies's revenue was $4.05 million, an increase of 2688.61% compared to the previous year's $145,291. Losses were -$13.56 million, -54.54% less than in 2023.